These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 24919577)

  • 1. A review of the pharmacological effects of piceatannol on cardiovascular diseases.
    Tang YL; Chan SW
    Phytother Res; 2014 Nov; 28(11):1581-8. PubMed ID: 24919577
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Comprehensive Review on the Chemotherapeutic Potential of Piceatannol for Cancer Treatment, with Mechanistic Insights.
    Seyed MA; Jantan I; Bukhari SN; Vijayaraghavan K
    J Agric Food Chem; 2016 Feb; 64(4):725-37. PubMed ID: 26758628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biological activity of piceatannol: leaving the shadow of resveratrol.
    Piotrowska H; Kucinska M; Murias M
    Mutat Res; 2012; 750(1):60-82. PubMed ID: 22108298
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postharvest accumulation of resveratrol and piceatannol in sugarcane with enhanced antioxidant activity.
    Boue SM; Shih BY; Burow ME; Eggleston G; Lingle S; Pan YB; Daigle K; Bhatnagar D
    J Agric Food Chem; 2013 Sep; 61(35):8412-9. PubMed ID: 23931742
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploring the therapeutic potential of naturally occurring piceatannol in non-communicable diseases.
    Gandhi H; Mahant S; Sharma AK; Kumar D; Dua K; Chellappan DK; Singh SK; Gupta G; Aljabali AAA; Tambuwala MM; Kapoor DN
    Biofactors; 2024; 50(2):232-249. PubMed ID: 37702264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacometrics of stilbenes: seguing towards the clinic.
    Roupe KA; Remsberg CM; Yáñez JA; Davies NM
    Curr Clin Pharmacol; 2006 Jan; 1(1):81-101. PubMed ID: 18666380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Therapeutic Potential of Piceatannol, a Natural Stilbene, in Metabolic Diseases: A Review.
    Kershaw J; Kim KH
    J Med Food; 2017 May; 20(5):427-438. PubMed ID: 28387565
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Piceatannol and resveratrol share inhibitory effects on hydrogen peroxide release, monoamine oxidase and lipogenic activities in adipose tissue, but differ in their antilipolytic properties.
    Les F; Deleruyelle S; Cassagnes LE; Boutin JA; Balogh B; Arbones-Mainar JM; Biron S; Marceau P; Richard D; Nepveu F; Mauriège P; Carpéné C
    Chem Biol Interact; 2016 Oct; 258():115-25. PubMed ID: 27475863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of proliferation and migration by piceatannol in vascular smooth muscle cells.
    Lee B; Lee EJ; Kim DI; Park SK; Kim WJ; Moon SK
    Toxicol In Vitro; 2009 Oct; 23(7):1284-91. PubMed ID: 19631264
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiproliferative and anti-invasive effect of piceatannol, a polyphenol present in grapes and wine, against hepatoma AH109A cells.
    Kita Y; Miura Y; Yagasaki K
    J Biomed Biotechnol; 2012; 2012():672416. PubMed ID: 22496613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Cardiovascular Nutrapharmacology of Resveratrol: Pharmacokinetics, Molecular Mechanisms and Therapeutic Potential.
    Kroon PA; Iyer A; Chunduri P; Chan V; Brown L
    Curr Med Chem; 2010; 17(23):2442-55. PubMed ID: 20491649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Therapeutic Potential and Molecular Targets of Piceatannol in Chronic Diseases.
    Surh YJ; Na HK
    Adv Exp Med Biol; 2016; 928():185-211. PubMed ID: 27671818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Involvement of heme oxygenase-1 expression in neuroprotection by piceatannol, a natural analog and a metabolite of resveratrol, against glutamate-mediated oxidative injury in HT22 neuronal cells.
    Son Y; Byun SJ; Pae HO
    Amino Acids; 2013 Aug; 45(2):393-401. PubMed ID: 23712764
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Piceatannol is superior to resveratrol in promoting neural stem cell differentiation into astrocytes.
    Arai D; Kataoka R; Otsuka S; Kawamura M; Maruki-Uchida H; Sai M; Ito T; Nakao Y
    Food Funct; 2016 Oct; 7(10):4432-4441. PubMed ID: 27713945
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interaction of the chemopreventive agent resveratrol and its metabolite, piceatannol, with model membranes.
    Wesołowska O; Kuzdzał M; Strancar J; Michalak K
    Biochim Biophys Acta; 2009 Sep; 1788(9):1851-60. PubMed ID: 19527681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phosphoinositide 3-kinase is a novel target of piceatannol for inhibiting PDGF-BB-induced proliferation and migration in human aortic smooth muscle cells.
    Choi KH; Kim JE; Song NR; Son JE; Hwang MK; Byun S; Kim JH; Lee KW; Lee HJ
    Cardiovasc Res; 2010 Mar; 85(4):836-44. PubMed ID: 19887493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piceatannol, a natural trans-stilbene compound, inhibits human glyoxalase I.
    Takasawa R; Akahane H; Tanaka H; Shimada N; Yamamoto T; Uchida-Maruki H; Sai M; Yoshimori A; Tanuma SI
    Bioorg Med Chem Lett; 2017 Mar; 27(5):1169-1174. PubMed ID: 28169168
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of long-term piceatannol treatment on eNOS levels in cultured endothelial cells.
    Kinoshita Y; Kawakami S; Yanae K; Sano S; Uchida H; Inagaki H; Ito T
    Biochem Biophys Res Commun; 2013 Jan; 430(3):1164-8. PubMed ID: 23246837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol and Cardiovascular Diseases.
    Bonnefont-Rousselot D
    Nutrients; 2016 May; 8(5):. PubMed ID: 27144581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Resveratrol and cardiovascular health--promising therapeutic or hopeless illusion?
    Tang PC; Ng YF; Ho S; Gyda M; Chan SW
    Pharmacol Res; 2014 Dec; 90():88-115. PubMed ID: 25151891
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.